Hospital margins highest in trade of stents: Report

In December, the NPPA said it was working on fixing ceiling prices of stents as the government notified it in the Drug Prices Control Order (DPCO), 2013.

By: Express Web Desk | New Delhi | Updated: January 18, 2017 11:12 am
superbug, delhi superbug, antiobiotics superbug, delhi superbug, Enterobacteriaceae, CRE, health news, world news (Representational image/Thinkstock)

National drug pricing regulator NPPA Tuesday put out data on the margins made by players in the trade of stents which showed that hospitals charged the most, a report in The Times of India said. Stents are mesh tubes that are placed in arteries as part of coronary angioplasty in order to treat weak or narrow arteries.

The report said hospital margins sometimes touched almost 650 per cent although not all hospitals charged so much. The NPPA data was based on the figures produced by stent companies and pointed to almost ten-time jump in the price of stents by the time it reaches the patient. The margins also seemed to differ between drug-eluting stents and bare-metal stents. Stents used for surgeries in India are mostly of the drug-eluting variety.

The TOI report also mentions how even though the manufacturers are shown to make the lowest margins, they sometimes indulge in illegal marketing practices.

In December, the NPPA said it was working on fixing ceiling prices of stents as the government notified it in the Drug Prices Control Order (DPCO), 2013. At that time, the Advanced Medical Technology Association (AdvaMed) told PTI the move hinders the fundamental right of a patient to have access to advanced, clinically proven, patient condition-specific and high-quality devices. Hospital associations in the past have argued that putting price controls on stents may affect patients looking for innovative and newer technologies in imported stents.

(With inputs from PTI)

For all the latest India News, download Indian Express App

  1. Aaron Paul
    Jan 28, 2017 at 7:53 am
    Primus Hospital is the Best Hospital in Delhi and is being recognized all across the world. The hospital is one of the biggest and the best multi-speciality care hospitals with over 700 beds in India. It is one of the most sought after destination in SAARC region for healthcare delivery.lt;br/gt;lt;br/gt;Primus Super Speciality Hospitallt;br/gt;lt;br/gt;2, chandragupt Marg, Chanakyapuri,lt;br/gt;New Delhi- 110021, Indialt;br/gt;011 - 66206620, 9953722892lt;br/gt;lt;br/gt;
    (0)(0)
    Reply
    1. A
      arc
      Jan 18, 2017 at 9:01 am
      Just find our how much Modi's health minister piyush goyal is charging for stents at his privately owned hospital in noida.
      (0)(0)
      Reply
      1. B
        Bhavadas T
        Jan 18, 2017 at 10:43 am
        Any escape for Aam Admi from exploitation by middle men (Agents/distributers) and Hospitals. Is the Govt. helpless in controlling importers, hospitals etc.lt;br/gt;lt;br/gt;At least are the agents and hospitals accounting their profit and paying income tax?
        (0)(0)
        Reply
        1. Prem
          Jan 18, 2017 at 6:01 am
          Presentation ranks better than merits of any issue n best brains can be rented to make impressive presentation dosa a case. 650% margin in stents cab be thus justified n the government can be thus convinced. However such luxury or avenue is not available to patients. Hence government must not get brow- beaten by sophisticated presentation buy also make its dispionate evaluation of this stent issue to stop huge loot under the name profiteering. By the way middlemen n retailers making much more money than the actual producers/manufacturers is a sad position plaguing the nation since a long time and crying for attention.
          (0)(0)
          Reply
          1. S
            Sanjeev
            Jan 18, 2017 at 7:27 am
            Most MNCs have made big money and already exited the stent business and now NPPA will crack down upon small time players. All these years they were looking the other way.lt;br/gt;If NPPA is really concerned, it should control prizes of artificial knees, hips and other implants imported by MNCs who make money under transfer price mechanism and don't show profits in India.lt;br/gt;The hospital charges are much higher that the cost of implant, why are all bodies sleeping on that issue.
            (0)(0)
            Reply
            1. Load More Comments